McKesson MCK Business Segments
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| Medical-Surgical Solutions | $11.51B+1.1% | $11.49B+1.1% | $11.45B0.0% | $11.45B+1.0% | $11.38B+0.7% | |
| North American Pharmaceutical | $336.65B+10.6% | $334.48B+14.2% | $327.35B+18.2% | $320.89B+22.3% | $304.51B+16.5% | |
| Oncology & Multispecialty | $48.42B+31.4% | $45.14B+28.8% | $41.63B+25.4% | $38.74B+22.4% | $36.86B+20.9% | |
| Prescription Technology Solutions | $5.81B+11.3% | $5.65B+11.7% | $5.52B+12.9% | $5.41B+13.5% | $5.22B+9.4% | |
| Total long-lived assets by Geography | ||||||
| Foreign | $1.1B— | $1.15B— | —— | —— | —— | |
| United States | $12.35B— | $12.05B— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does McKesson break its business down?
- McKesson (MCK) reports total revenues by business across 4 parts — Medical-Surgical Solutions, North American Pharmaceutical, Oncology & Multispecialty and Prescription Technology Solutions. Each is extracted from the segment footnotes and tracked over time.
- Where does McKesson's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in McKesson's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
